These changes include the following: Decreased levels of HbA1c levels Improved fasting glucose levels Improved insulin levels Reduced levels of LDL, triglyceride, and cholesterol After 48 weeks, 72% of prediabetic patients reverted to normoglycemia (normal blood sugar levels) as compared to 22% of participants in the placebo group
Weight loss, improved insulin sensitivity, and reduced systemic inflammationall potential effects of GLP-1 treatmentare associated with better long-term outcomes in breast cancer survivors
This is where bioavailability becomes the most important part of the conversation
Cochrane Database of Systematic Reviews Issue 10;CD011737
The fates of fatty acyl-CoAs, in the brain, are conversion into various structural entities including phospholipids, triglycerides, diacylglycerides, and fatty acyl-carnitine species as well as lipid-derived signaling molecules